ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
AN2 Therapeutics Inc

AN2 Therapeutics Inc (ANTX)

2.11
0.04
(1.93%)
Closed June 22 4:00PM
2.0204
-0.0896
(-4.25%)
After Hours: 6:56PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.0204
Bid
2.02
Ask
3.80
Volume
94,878
2.01 Day's Range 2.14
1.91 52 Week Range 22.22
Market Cap
Previous Close
2.07
Open
2.06
Last Trade
3
@
2.1
Last Trade Time
Financial Volume
$ 195,172
VWAP
2.0571
Average Volume (3m)
221,628
Shares Outstanding
29,829,040
Dividend Yield
-
PE Ratio
-0.97
Earnings Per Share (EPS)
-2.17
Revenue
-
Net Profit
-64.73M

About AN2 Therapeutics Inc

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NT... AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Dover, Delaware, USA
Founded
1970
AN2 Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ANTX. The last closing price for AN2 Therapeutics was $2.07. Over the last year, AN2 Therapeutics shares have traded in a share price range of $ 1.91 to $ 22.22.

AN2 Therapeutics currently has 29,829,040 shares outstanding. The market capitalization of AN2 Therapeutics is $62.94 million. AN2 Therapeutics has a price to earnings ratio (PE ratio) of -0.97.

ANTX Latest News

AN2 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business and Scientific Highlights

Plan to report Phase 2 topline results in August 2024 from ongoing Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) Phase 3 continues for 97 patients...

AN2 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business and Scientific Highlights

Phase 2/3 trial (EBO-301) in treatment-refractory Mycobacterium avium Complex (TR-MAC) continues with Phase 2 topline results expected in summer 2024 and Phase 3 enrollment pause in place during...

AN2 to Voluntarily Pause Enrollment in Phase 3 Part of Phase 2/3 Pivotal Clinical Trial Evaluating Epetraborole for Treatment-Refractory Mycobacterium Avium Complex (MAC) Lung Disease

-Enrolled patients allowed to continue on study- AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.04042.04040404041.982.181.959871882.0930867CS
40.01040.5174129353232.012.181.911682032.01913609CS
12-1.3896-40.75073313783.413.881.912216282.67760653CS
26-18.3796-90.096078431420.422.221.913119534.76275868CS
52-5.0896-71.58368495087.1122.221.911993466.64248793CS
156-14.8296-88.00949554916.8523.581.911177347.93930527CS
260-14.8296-88.00949554916.8523.581.911177347.93930527CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AREBAmerican Rebel Holdings Inc
$ 0.76
(152.49%)
371.46M
SHCRSharecare Inc
$ 1.365
(76.27%)
56.33M
NXLNexalin Technologies Inc
$ 1.7499
(59.08%)
57.58M
FUFUBitFuFu Inc
$ 6.1209
(56.95%)
2.5M
SPECSpectaire Holdings Inc
$ 0.50
(47.06%)
65.27M
FLFVFeutune Light Acquisition Corporation
$ 2.5502
(-69.75%)
862.38k
FLFVUFeutune Light Acquisition Corporation
$ 2.75
(-66.83%)
16.5k
RWODRedwoods Acquisition Corporation
$ 2.34
(-60.34%)
155.96k
KAVLKaival Brands Innovations Group Inc
$ 1.23
(-57.14%)
4.92M
RWODURedwoods Acquisition Corporation
$ 3.24
(-56.28%)
1.47k
NVDANVIDIA Corporation
$ 126.57
(-3.22%)
658.13M
AREBAmerican Rebel Holdings Inc
$ 0.76
(152.49%)
371.46M
SIRISirius XM Holdings Inc
$ 2.94
(1.38%)
330.66M
AAPLApple Inc
$ 207.49
(-1.04%)
246.38M
NKLANikola Corporation
$ 0.3466
(5.16%)
193.36M

ANTX Discussion

View Posts
GO4AWILDRIDE GO4AWILDRIDE 3 months ago
FROM 3/28 NEWS:

Cash, cash equivalents, and investments of $134.5 million at December 31, 2023

GO4AWILDRIDE
πŸ‘οΈ0
GO4AWILDRIDE GO4AWILDRIDE 3 months ago
THE FOLLOWING FROM THE 3/28 NEWS:

β€œAN2’s cash position remains strong as we advance our innovative boron-based pipeline. Following the recent meeting of the independent Data Safety Monitoring Board, we continue to believe in the potential of epetraborole to become an important component of the backbone therapy for NTM lung disease,” said Eric Easom, Co-Founder, President and Chief Executive Officer. β€œPatients enrolled in the epetraborole Phase 2/3 trial in treatment refractory lung disease caused by MAC continue to be dosed while new enrollment in the Phase 3 part of the trial remains paused. Patients in the Phase 2 trial have reached the six-month mark, and we plan to report topline results this summer. Analysis of the baseline patient demographics from the trial show a highly complex and refractory patient population, which we plan to discuss with the FDA in the coming months.”

GO4AWILDRIDE
πŸ‘οΈ0
GO4AWILDRIDE GO4AWILDRIDE 3 months ago
Monksdream

Did you read the 3/28 news from the compay?

Seems like the market is looking to chase the price up.

GLTU

GO4AWILDRIDE
πŸ‘οΈ0
GO4AWILDRIDE GO4AWILDRIDE 3 months ago
Monksdream

Seems like a nice rebound is starting to occur.

GLTU

GO4AWILDRIDE
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
ANTX new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
ANTX new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 4 months ago
ANTX new 52 week low
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock